Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

Phase III briakinumab data analyzed

Oct. 26, 2011

Phase III trial shows safety/tolerability of BG-12 in MS

Oct. 25, 2011

AMG-827 improves quality of life in patients with plaque psoriasis

Oct. 25, 2011

Phase II and III data presented on vorinostat

Oct. 25, 2011

Therapy benefits children with Tay-Sachs and Sandhoff's diseases / News in Context

Oct. 25, 2011

Study finds biomarkers of metastatic disease progression in prostate cancer

Oct. 25, 2011

First-in-human AVI-6003 trial advances

Oct. 24, 2011

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...